Shopping Cart
Remove All
Your shopping cart is currently empty
AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporating the natural bis-intercalator SW-163D through an AcLysValCit-PABC-DMAE linker[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Backorder | Backorder | |
| 500 mg | Inquiry | Backorder | Backorder |
| Description | AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporating the natural bis-intercalator SW-163D through an AcLysValCit-PABC-DMAE linker[1]. |
| In vitro | SW-163D, a cyclodepsipeptide antibiotic sourced from Streptomyces sp., demonstrates antitumor properties. PF06888667, characterized as a potent, stable, and effective Antibody-Drug Conjugate (ADC), comprises SW-163D linked to an engineered variant of trastuzumab, an anti-Her2 monoclonal antibody (mAb), through an N-acetyl-lysine-valine-citrulline-p-aminobenzyl alcohol-N,N-dimethylethylenediamine (AcLysValCitPABC-DMAE) linker. This conjugation is facilitated by transglutaminase. |
| Molecular Weight | 1817.07 |
| Formula | C85H113N19O22S2 |
| Cas No. | 2411007-69-5 |
| Relative Density. | 1.43 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.